胃经口内镜下幽门肌切开术可减轻难治性胃轻瘫患者的症状、提高生活质量并减少医疗资源使用
该回顾性研究纳入30例接受胃经口内镜下幽门肌切开术(GPOEM)的难治性胃轻瘫患者,并与7例未手术对照比较。GPOEM后胃轻瘫主要症状指数(GCSI)显著降低、SF-36生活质量多个方面显著改善,胃轻瘫相关急诊就诊和住院次数显著减少。
要点
- GPOEM后GCSI评分从基线3.5±0.6降至1个月1.8±1.0、6个月1.9±1.2、12个月2.6±1.5、18个月2.1±1.3(均P<.05)。
- GPOEM后1、6、12个月分别有77.8%、76.5%、70%的患者SF-36评分较基线显著提高(F1.71,18.83=14.16;P<.0005)。
- GPOEM组急诊就诊从基线2.2±3.1次/月降至0.3±0.8次/月(P=.003),住院从1.7±2次/月降至0.2±0.4次/月(P=.0002)。
核心结论
- 在难治性胃轻瘫患者中,GPOEM显著改善症状、提高生活质量并减少胃轻瘫相关的医疗资源使用。
研究设计与样本
- 回顾性研究,纳入2015年6月至2017年7月在一家三级中心接受GPOEM的30例难治性胃轻瘫患者,并与7例未接受该手术的难治性胃轻瘫对照者比较。
主要发现
- GPOEM在所有患者中技术成功,重复测量方差分析显示GCSI评分显著降低(F2.044,38.838=22.319;P<.0005)。
- GCSI平均分基线为3.5±0.6,GPOEM后1个月为1.8±1.0(P<.0005)、6个月为1.9±1.2(P<.0005)、12个月为2.6±1.5(P<.026)、18个月为2.1±1.3(P<.016)。
- GPOEM后1个月、6个月、12个月分别有77.8%、76.5%、70%的患者SF-36评分较基线显著提高(F1.71,18.83=14.16;P<.0005)。
- 控制基线评分和疾病病程后,GPOEM组GCSI较对照组显著降低(F1,31=9.001;P=.005)。
- GPOEM组急诊就诊次数从基线2.2±3.1次/月降至0.3±0.8次/月(P=.003),住院次数从1.7±2次/月降至0.2±0.4次/月(P=.0002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Gastric peroral endoscopic pyloromyotomy (GPOEM) is becoming a promising treatment option for patients with refractory gastroparesis. We aimed to systematically assess the efficacy of GPOEM and its effects on health care use. METHODS: We performed a retrospective study on 30 patients with refractory gastroparesis who underwent GPOEM from June 2015 through July 2017 at a tertiary center. We compared outcomes with those of 7 patients with refractory gastroparesis who did not undergo the procedure (controls). The primary outcomes were patient-reported reductions in symptoms, based on the gastroparesis cardinal symptom index (GCSI), and increases in 8 aspects of quality of life, based on Short Form 36 (SF-36) scores. Data were collected on the day of the procedure (baseline) and at 1 month, 6 months, 12 months, and 18 months afterward. Secondary outcomes included visits to the emergency department or hospitalization for gastroparesis-related symptoms. RESULTS: GPOEM was technically successful in all patients and significantly reduced GCSI scores in repeated-measure analysis of variance (F2.044, 38.838 = 22.319; P < .0005). The mean score at baseline was 3.5 ± 0.6, at 1 month after GPOEM was 1.8 ± 1.0 (P < .0005), at 6 months after was 1.9 ± 1.2 (P < .0005), at 12 months after was 2.6 ± 1.5 (P < .026), and at 18 months after was 2.1 ± 1.3 (P < .016). GPOEM was associated with improved quality of life: 77.8%, 76.5%, and 70% of patients had significant increases in SF-36 scores, compared with baseline, at 1 month, 6 months, and 12 months after GPOEM, respectively (F1.71,18.83 = 14.16; P < .0005). Compared with controls, patients who underwent GPOEM had significant reductions in GCSI, after we controlled for baseline score and duration of the disease (F1,31 = 9.001; P = .005). Patients who received GPOEM had significant reductions in number of emergency department visits (from 2.2 ± 3.1 times/mo at baseline to 0.3 ± 0.8 times/mo; P = .003) and hospitalizations (from 1.7 ± 2 times/mo at baseline to 0.2 ± 0.4 times/mo; P = .0002). CONCLUSIONS: In a retrospective study of patients who underwent GPOEM for refractory gastroparesis, we found the procedure significantly improved symptoms, increased quality of life, and reduced health care use related to gastroparesis.
引用
- Mekaroonkamol P, Dacha S, Wang L, et al. Gastric Peroral Endoscopic Pyloromyotomy Reduces Symptoms, Increases Quality of Life, and Reduces Health Care Use For Patients With Gastroparesis. Clin Gastroenterol Hepatol. 2018. PMID: 29660525. doi:10.1016/j.cgh.2018.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。